Skip to main content

Regulatory and Washington

  • Reports: Congressmen accuse companies of drug price gouging

    NEW YORK — Lawmakers are going after companies that they say have sought to take advantage of drug shortages by buying drugs in short supply and then reselling them at higher prices, according to published reports.

  • NRF names VP communications

    WASHINGTON — The National Retail Federation has appointed a new VP communications.

    Effective Apr. 9, Katie Wilson will be responsible for overseeing NRF’s industry efforts, a multitude of communication vehicles and advancing NRF advocacy priorities on issues important to the retail community, NRF said. She will assume many of the responsibilities of Ellen Davis, who was recently named NRF SVP and executive director of the NRF Foundation.

  • FDA opens dialogue of incorporating technology, pharmacy into switch paradigm

    SILVER SPRING, Md. — The Food and Drug Administration's director of the Center for Drug Evaluation and Research, Janet Woodcock, on Thursday identified three tools the agency wanted to use in potentially increasing access to appropriate medicines in her opening remarks at the FDA Rx-to-OTC Switch Hearing held here.

  • NACDS RxImpact Day 'astounding' as pharmacy advocates conduct more than 350 congressional meetings

    ALEXANDRIA, Va. — NACDS RxImpact Day on Capitol Hill showcased the unsurpassed value of community pharmacy as pharmacy advocates from 41 states conducted more than 350 meetings with U.S. senators and representatives this week.

    Community pharmacy advocates — including pharmacists, pharmacy students and other pharmacy supporters — met with 86% of members of Congress who serve on congressional committees with jurisdiction on healthcare issues.

  • GSK shares real-world example on how to improve switch through technology

    SILVER SPRING, Md. — GlaxoSmithKline on Thursday morning presented exactly how technology might improve appropriate patient self-selection before a panel convened by the Food and Drug Administration to explore expanding the prescripton-to-over-the-counter switch paradigm by incorporating technology and/or pharmacy participation in the application process.

  • FMI names new director of government relations

    ARLINGTON, Va. — The Food Marketing Institute on Thursday named Hannah Walker director of government relations to represent food retailers on Capitol Hill.

  • FDA advisory committee votes in favor of GSK's Votrient

    PHILADELPHIA — A Food and Drug Administration expert panel delivered a favorable vote on a cancer drug made by GlaxoSmithKline.

    GSK announced that the FDA Oncologic Drugs Advisory Committee voted 11-2 that clinical trial data indicated a favorable risk-benefit profile of the drug Votrient (pazopanib) in patients with advanced soft-tissue sarcoma who have received chemotherapy. The drug is already approved for treating the kidney cancer renal cell carcinoma.

  • NRF names head of research division

    WASHINGTON — The National Retail Federation has named Ellen Davis SVP and executive director of the NRF Foundation, the education and research arm of NRF.

X
This ad will auto-close in 10 seconds